🔎 Trials Near Me

Acasă › BPOC › Florida › Miami

Studii clinice pentru BPOC în Miami, FL

18 studii pentru BPOC caută participanți în și în jurul orașului Miami (în aproximativ 50 km). Deschideți un studiu pentru a vedea criteriile de eligibilitate și cum să contactați echipa de cercetare.

Text oficial al studiului (în engleză)

Recrutați pentru un studiu aici? Promovați-l în partea de sus a acestei pagini — $99 pentru 30 de zile →

Efficacy, Safety, and Tolerability Study of Lunsekimig Compared With Placebo in Adult Participants With Inadequately Controlled Chronic Obstructive Pulmonary Disease (COPD), Characterized by an Eosinophilic Phenotype

În curs de recrutareFaza 3
  • Elite Clinical Research - Miami- Site Number : 8400167, Miami
  • DL Research Solutions- Site Number : 8400140, Miami
  • Phoenix Medical Research - Miami - 24th Street- Site Number : 8400027, Miami
  • și încă 3
Vârste de la 40 la 80 · Toate sexele · Actualizat 1 oct. 2026 · NCT07190222

To Evaluate the Effect of EXPD-101/FXS7553 Compared With Placebo in Patients With COPD Over 52 Weeks of Treatment

În curs de recrutareFaza 2
  • Suncoast Research Group, LLC Miami - Little Havana dba Flourish Research, Miami
Vârste de la 40 la 85 · Toate sexele · Actualizat 30 sept. 2026 · NCT07684820

A Study of Brenipatide (LY3537031) in Adult Participants With Moderate-to-Severe Chronic Obstructive Pulmonary Disease (COPD)

În curs de recrutareFaza 2
  • Millennium Medical Research - Miami, Miami
Vârste de la 40 la 75 · Toate sexele · Actualizat 25 sept. 2026 · NCT07759245

A Study to Investigate the Efficacy and Safety of GSK5784283 (Felcorekibart) Compared With Placebo in Participants With Moderate to Very Severe COPD (PERSIST COPD-2)

În curs de recrutareFaza 3
  • GSK Investigational Site, Miami
Vârste de la 40 la 80 · Toate sexele · Actualizat 25 sept. 2026 · NCT07780656

A Study to Investigate Airway Inflammation With Dupilumab Subcutaneously in Participants Aged ≥40 to ≤85 Years With Chronic Obstructive Pulmonary Disease.

În curs de recrutareFaza 4
  • University of Miami Dermatology Clinical Trials Unit- Site Number : 8400015, Miami
  • Finlay Medical Research- Site Number : 8400010, Miami
Vârste de la 40 la 85 · Toate sexele · Actualizat 22 sept. 2026 · NCT07053423

Efficacy, Safety, and Tolerability Study of Lunsekimig Compared With Placebo in Adult Participants With Inadequately Controlled Chronic Obstructive Pulmonary Disease (COPD) Characterized by an Eosinophilic Phenotype

În curs de recrutareFaza 3
  • University of Miami Dermatology Clinical Trials Unit- Site Number : 8400078, Miami
  • MCR Research- Site Number : 8400004, Miami
  • Nuren Medical & Research Center- Site Number : 8400030, Miami
  • și încă 1
Vârste de la 40 la 80 · Toate sexele · Actualizat 22 sept. 2026 · NCT07190209

A Study to Investigate the Effect of AZD6793 in Participants With Moderate to Very Severe Chronic Obstructive Pulmonary Disease

În curs de recrutareFaza 2
  • Research Site, Miami
  • Research Site, Miami
  • Research Site, Miami
  • și încă 2
Vârste de 40 ani și peste · Toate sexele · Actualizat 9 sept. 2026 · NCT07082738

A Study to Investigate the Efficacy and Safety of Tezepelumab in Adult Participants With Moderate to Very Severe COPD (D5241C00007)

În curs de recrutareFaza 3
  • Research Site, Miami
Vârste de la 40 la 80 · Toate sexele · Actualizat 3 sept. 2026 · NCT06878261

A Study to Investigate the Efficacy and Safety of Tezepelumab in Adult Participants With Moderate to Very Severe COPD (D5241C00006)

În curs de recrutareFaza 3
  • Research Site, Miami
  • Research Site, Miami
  • Research Site, Miami
Vârste de la 40 la 80 · Toate sexele · Actualizat 3 sept. 2026 · NCT06883305

A Study to Learn About the Study Medicine Called PF-07275315 in People With Moderate to Severe Chronic Obstructive Pulmonary Disease

În curs de recrutareFaza 2/3
  • Reed Medical Research, Miami
Vârste de la 35 la 80 · Toate sexele · Actualizat 31 aug. 2026 · NCT07363694

Rademikibart IV for Acute Asthma and COPD Exacerbation

În curs de recrutareFaza 2
  • Columbus Clinical Services, LLC, Miami
  • Pharmax Research of South Florida, Inc., Miami
Vârste de la 18 la 85 · Toate sexele · Actualizat 27 aug. 2026 · NCT07705737

A Study Evaluating the Efficacy of Budesonide, Glycopyrronium and Formoterol Fumarate Metered Dosed Inhaler on Cardiopulmonary Outcomes in Chronic Obstructive Pulmonary Disease

În curs de recrutareFaza 3
  • Research Site, Miami
  • Research Site, Miami
Vârste de la 40 la 80 · Toate sexele · Actualizat 26 aug. 2026 · NCT06283966

eValuating the Efficacy and Safety of InitiatinG depemokImab earLy therApy iN Chronic Obstructive Pulmonary Disorder (COPD) With Type 2 Inflammation

În curs de recrutareFaza 3
  • GSK Investigational Site, Miami
  • GSK Investigational Site, Miami
  • GSK Investigational Site, Miami
Vârste de la 40 la 75 · Toate sexele · Actualizat 28 iul. 2026 · NCT07177339

Physiologic Effects of Nasal High Flow on Exercise Tolerance in COPD

În curs de recrutare
  • University of Miami, Miami
Vârste de la 18 la 100 · Toate sexele · Actualizat 22 iun. 2026 · NCT06578156

Depemokimab as an Extended treatmeNt Duration Biologic in Adults With Chronic Obstructive Pulmonary Disease (COPD) and Type 2 Inflammation (ENDURA-2)

În curs de recrutareFaza 3
  • GSK Investigational Site, Miami
  • GSK Investigational Site, Miami
  • GSK Investigational Site, Miami
  • și încă 4
Vârste de la 40 la 80 · Toate sexele · Actualizat 9 apr. 2026 · NCT06961214

Depemokimab as an Extended treatmeNt Duration Biologic in Adults With Chronic Obstructive Pulmonary Disease (COPD) and Type 2 Inflammation (ENDURA -1)

În curs de recrutareFaza 3
  • GSK Investigational Site, Miami
Vârste de la 40 la 80 · Toate sexele · Actualizat 8 oct. 2025 · NCT06959095

myAirvo 3 (High Flow Nasal Therapy; HFNT) for COPD Patients in the Home

În curs de recrutare
  • Reliable Research, Inc., Miami
  • NewGen Health Group, Miami
Vârste de 30 ani și peste · Toate sexele · Actualizat 6 feb. 2025 · NCT05204888

Studii pentru BPOC în alte orașe

Alte studii în Miami

Sursă: ClinicalTrials.gov, date preluate la 2 oct. 2026. Fiecare studiu are propriile criterii de eligibilitate; echipa de cercetare decide cine poate participa.